<div id="readability-page-1"><div><p>Hologic, Inc. will be presented at the Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, Illinois. In a study led by Dr. Manisha Bahl, M.D., MPH, FSBI, Associate Medical Director of Quality at Mass General Brigham and Associate Professor of Radiology at Harvard Medical School, researchers at Massachusetts General Hospital evaluated Hologic's 3DQuorum imaging technology. Based on more than 160,000 screening mammography exams, the retrospective study compared cancer detection rates before and after adopting 3DQuorum imaging technology, which uses AI to reduce the number of 3D imaging &#34;slices&#34; radiologists need to review without compromising image quality, sensitivity or accuracy.</p><p>In the simplest terms, the technology is comparable to condensing a 60-page book into a 10-page summary that retains all relevant information and highlights key findings. The study found no significant difference in cancer detection rates after implementation of 3DQuorum. With ongoing radiologist shortages, these results suggest the technology's potential to streamline radiologists' workflows and save valuable time while maintaining high effectiveness in detecting cancers.</p><p>Another study, led by Professor Yan Chen, Ph.D., Chair of Digital Screening and Head of the Digital Cancer Screening Research Group at the University of Nottingham, U.K., looked at Hologic's Genius AI®? Detection solution compared with radiologists. In this study, 108radiologists from the U.K. and U.S. reviewed 75 challenging breast cancer cases, and the AI system assessed the same cases.</p><p>Overall, the AI technology performed similarly to radiologists. It detected more cancers but also showed lower specific, meaning it could flag more false positives. Although the study is still ongoing, these initial findings indicate that AI could help radiologists manage workloads in settings where double reading by multiple radiologists is required but staffing may be limited.</p><p>Hologic will also showcase its latest innovations at RSNA, including the AI-powered Genius AI Detection suite of products, leading breast surgery technologies and the next-generation Envision?? Mammography Platform with tilt positioning designed to adapt to patients. The company will host multiple medical education events throughout the congress, spanning the latest technologies in AI, contrast-enhanced mammography (CEM) and breast surgery.</p></div></div>

豪洛捷

<p>霍洛捷公司将在芝加哥的 RSNA 会议上展示其最新创新。由 Manisha Bahl 博士和 Yan Chen 教授领导的研究分别评估了霍洛捷的 3DQuorum 成像技术和 Genius AI 检测解决方案。3DQuorum 技术在不影响癌症检测率的情况下简化了放射科医生的工作流程，而 AI 解决方案的表现与放射科医生相似，有助于工作负载管理。霍洛捷还将展示基于 AI 的产品、乳腺手术技术以及 Envision 乳腺摄影平台，并举办关于 AI、CEM 和乳腺手术的教育活动</p>

豪洛捷公司将在北美放射学会年会上展示其最新的创新技术